Moderna Inc said the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunisation Practices voted to recommend the use of the company's COVID-19 vaccine on people 18 years of age and older.
The panel voted 11-0 in favour of the vaccine, the company said in a press release.
The vote result came a day after the Food and Drug Administration's authorisation for emergency use of Moderna's COVID-19 vaccine.
"ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine," Chief Executive Officer Stephane Bancel said in the release.
Moderna's is the second COVID-19 vaccine to receive approval in the United States after a similar vaccine from Pfizer Inc and German partner BioNTech SE got the green light for emergency use.
US distribution of Moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.
Shooting at Australia's Bondi Beach kills 12
Police hold person of interest after Brown University shooting leaves two dead
Hamas says Israel's killing of senior commander threatens ceasefire
Ukraine's Zelenskyy ditches NATO ambition ahead of peace talks
Thailand declares curfew along coast as Cambodia border fighting spreads
India tightens pollution curbs as Delhi's air quality worsens
'Peace is not far away' says Erdogan after Putin meeting
Belarus frees Nobel winner, protest figures as US lifts more sanctions
